News & Insights

Pharma & Biotech ×
Insights
10th December 2020

Cell and Gene Therapies: Challenges in Scale-up to Commercial Manufacturing

The cellular therapy and gene therapy fields are undergoing very rapid growth. This includes a large and growing number of products in the development pipeline, and new products with significant sales, including blockbusters, now entering world markets. Billions are being invested in research and commercial development with markets in $10s of billions expected in the […]

Insights
30th May 2020

Biotech share prices in this COVID-19 era and the rollercoaster impact of remdesivir

Although the exact numbers are yet to be known, the virus has claimed nearly 220,000 lives and infected more than 3 million people globally. The COVID-19 outbreak is proving every week to be more of an economic event than a sanitary one. Numerous economic data releases from various countries every week are gloomy and prove […]

Reports
27th May 2020

Generic Pharmaceutical Market: M&A Activity

The global generic pharmaceutical market has experienced robust deal activity over the last 18 months to the end of 2019 but is now contending with the COVID-19 crisis which has had an immediate and unprecedented impact on health systems. It is yet unclear what the long-term general impact on generic drug usage will be, but […]

Insights
20th May 2020

Moderna Coronavirus vaccine trial shows promising early results and the markets move positively

Every week is a roller coaster in the current COVID-19 environment. Most of us spend Sunday evenings preparing ourselves for the upcoming week and hoping for some positive developments on the healthcare, economy, or financial markets’ fronts. Luckily, on Monday, May 18th, Moderna’s coronavirus vaccine trial shed some light at the end of the tunnel […]

Insights
23rd April 2020

Will the spin-off of Sanofi pharmaceutical chemistry manufacturing happen now?

Earlier in 2020 in a pre-COVID-19 world, Sanofi announced its intention to spin off a significant part of their chemistry manufacturing capability with Sanofi sites in Brindisi, Italy; Frankfurt, Germany; Haverhill, England; St. Aubin les Elbeuf, France; Upjest, Hungary; and Vertolaye, France, forming a new company separated from Sanofi (but with Sanofi aspiring to own […]

Insights
14th April 2020

Life sciences supply chain resilience: now and post Covid-19

Without a doubt, life sciences supply chain resilience will be markedly different post Covid-19. There will be a massive restructuring generally of supply chains for strategic products such as drugs, diagnostics, personal safety equipment, food, chemicals etc., driven by national governmental actions in response to the Covid-19 pandemic. On the positive side, researchers have come […]

Insights
11th March 2020

Gene therapy: the challenge and the opportunity

Gene therapy is an experimental and therapeutic technique involving the engineering of genes with the hope to cure disease at its root cause. This has become an increasingly buoyant area for investment and although still at an early phase of development, there have been recent approvals of clinical and commercial gene therapies for use in […]

Insights
29th November 2019

Genomics: a source of future deal activity for the US

“Living in a world where a human genome can be sequenced for $100 is a future companies are increasingly preparing for by pursuing M&A and capital raising transactions.” Predicting an individual’s health has become a key area of focus as healthcare companies attempt to determine and reduce total lifetime healthcare costs for patients. The most […]

Reports
22nd November 2019

Outsourced Pharmaceutical Manufacturing 2020

Outsourced Pharmaceutical Manufacturing 2020: Current Trends & Future Prospects In our latest analysis of the commercial and clinical contract manufacturing market, we predict the sector to grow at a CAGR of 6.8% to c. $117bn in 2023, with certain sub-sectors such as viral vector and pre-filled syringe manufacturing achieving significant double-digit growth. The Contract Development […]

Subscribe

We add value by understanding our sectors inside-out, and we release regular industry research and reports on key trends in the technology and healthcare sectors. Fill out the form to start receiving alerts when we publish new content or to follow our latest deals, upcoming events and company updates.